Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natu... GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. The company was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.2897 | -13.7298578199 | 2.11 | 2.1559 | 1.72 | 208659 | 1.8737588 | CS |
| 4 | -0.2697 | -12.9043062201 | 2.09 | 2.35 | 1.72 | 121472 | 2.10795642 | CS |
| 12 | -0.4997 | -21.5387931034 | 2.32 | 2.77 | 1.72 | 110533 | 2.27917072 | CS |
| 26 | 1.4916 | 453.787648312 | 0.3287 | 6.7 | 0.186 | 1073515 | 0.8830433 | CS |
| 52 | 0.4803 | 35.8432835821 | 1.34 | 6.7 | 0.186 | 975084 | 1.25255215 | CS |
| 156 | -3.6697 | -66.8433515483 | 5.49 | 11.12 | 0.186 | 941355 | 1.13229339 | CS |
| 260 | -11.3797 | -86.2098484848 | 13.2 | 13.33 | 0.186 | 892280 | 1.14405886 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
